The U.S. Food and Drug Administration approved 2025-26 COVID-19 vaccines for anyone age 65 and older and any person 6 months and older who has at least one underlying health condition that increases ...
A public health expert explains why the United States is repeating the same mistake with the Hantavirus response as with ...
A new appellate decision from EEOC ordered a reversal of the denied religious exemptions, compensation for the affected ...
Plus, when it will actually be available in the U.S.
COVID-19 variant BA.3.2 or "cicada" is not widely circulating in the U.S. yet, but based on trends in Europe, it may become more prominent. Most evidence comes from laboratory data, but there are no ...
The US Food and Drug Administration (FDA) has green-lit updated COVID-19 vaccines for the 2025–26 season for select groups, but confusion is already mounting over how physicians and insurers will ...
As Covid-19 transmission ramps up in the United States, recent changes to federal vaccine guidance have left many Americans confused about the latest policies and concerned about access to shots this ...
The infant mortality rate in the United States rose for the first time in two decades between 2021 and 2022, but social media posts linking the uptick to Covid-19 vaccines are not supported by ...
School closures during the COVID-19 pandemic imposed enormous long-term costs while other measures delivered better health outcomes for far less money, according to new research led by Oxford ...
The hantavirus outbreak aboard the cruise ship MV Hondius has made headlines for weeks, and while U.S. health officials say ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results